These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9445885)

  • 1. [Case of hypertrophic cardiomyopathy with ventricular blood flow disparity after withdrawal of adrenergic beta antagonists].
    Bato K; Fukunaga Y; Fukuzaki M; Kawahata K
    Nihon Naika Gakkai Zasshi; 1997 Oct; 86(10):1964-6. PubMed ID: 9445885
    [No Abstract]   [Full Text] [Related]  

  • 2. Adrenergic hypersensitivity after beta-blocker withdrawal in hypertrophic cardiomyopathy.
    Gilligan DM; Chan WL; Stewart R; Oakley CM
    Am J Cardiol; 1991 Sep; 68(8):766-72. PubMed ID: 1892084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy.
    Matsubara H; Nakatani S; Nagata S; Ishikura F; Katagiri Y; Ohe T; Miyatake K
    J Am Coll Cardiol; 1995 Sep; 26(3):768-75. PubMed ID: 7642872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavior of both epicardial and intramural coronary artery flow velocities in various models of myocardial hypertrophy: role for left ventricular outflow tract obstruction.
    de Gregorio C; Micari A; Grimaldi P; Bragadeesh T; Arrigo F; Coglitore S
    Am Heart J; 2005 Jun; 149(6):1091-8. PubMed ID: 15976793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise echocardiography in hypertrophic cardiomyopathy-upright evaluation needed.
    Cotrim CA; Adame PR; Pereira HH
    Am J Cardiol; 2011 Apr; 107(7):1101-2; author reply 1102. PubMed ID: 21419892
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in left ventricular filling in obstructive cardiomyopathies during long term beta blockade].
    Roudaut R; Page A; Bricaud H; Dallocchio M; Besse P
    Arch Mal Coeur Vaiss; 1980; 73(3):268-75. PubMed ID: 6109524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy.
    Gadler F; Linde C; Juhlin-Dannfeldt A; Ribeiro A; Rydén L
    J Am Coll Cardiol; 1996 Apr; 27(5):1219-24. PubMed ID: 8609346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Withdrawal phenomena after chronic beta-blockade. Causes and therapeutic consequences].
    Krämer B; Kübler W
    Dtsch Med Wochenschr; 1984 Mar; 109(12):465-71. PubMed ID: 6142815
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of the ingestion of ethanol on obstruction of the left ventricular outflow tract in hypertrophic cardiomyopathy.
    Paz R; Jortner R; Tunick PA; Sclarovsky S; Eilat B; Perez JL; Kronzon I
    N Engl J Med; 1996 Sep; 335(13):938-41. PubMed ID: 8782501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled clinical trial of beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy (HOCM).
    Hubner P; Ziady G; Lane G; Pridie R; Scales J
    Br Heart J; 1972 Sep; 34(9):963. PubMed ID: 4403883
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta-adrenergic blockade in dynamic outflow obstruction.
    Sukumar IP; Chandrasekhara AS; Abraham T; Bose B; Kunhali K; Abraham KA; Cherian G
    J Assoc Physicians India; 1976 Nov; 24(11):737-43. PubMed ID: 15965
    [No Abstract]   [Full Text] [Related]  

  • 13. Propranolol withdrawal and myocardial infarction.
    Flach A
    JAMA; 1981 Jan 23-30; 245(4):342. PubMed ID: 7192753
    [No Abstract]   [Full Text] [Related]  

  • 14. [Beta-blocker withdrawal syndrome].
    Goliakov VN; Zimin IuV
    Klin Med (Mosk); 1984 Mar; 62(3):15-22. PubMed ID: 6143853
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical implications of midventricular obstruction and intravenous propranolol use in transient left ventricular apical ballooning (Tako-tsubo cardiomyopathy).
    Yoshioka T; Hashimoto A; Tsuchihashi K; Nagao K; Kyuma M; Ooiwa H; Nozawa A; Shimoshige S; Eguchi M; Wakabayashi T; Yuda S; Hase M; Nakata T; Shimamoto K
    Am Heart J; 2008 Mar; 155(3):526.e1-7. PubMed ID: 18294491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic cardiomyopathy. Combination of beta blockers and verapamil may be risky.
    Borja J; Izquierdo I; Guindo J
    BMJ; 2006 Jul; 333(7558):97. PubMed ID: 16825239
    [No Abstract]   [Full Text] [Related]  

  • 17. Withdrawal syndromes and the cessation of antihypertensive therapy.
    Hart GR; Anderson RJ
    Arch Intern Med; 1981 Aug; 141(9):1125-7. PubMed ID: 6114720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic obstruction to left ventricular outflow: the case for its existence in hypertrophic cardiomyopathy.
    Maron BJ; Epstein SE
    Z Kardiol; 1987; 76 Suppl 3():69-77. PubMed ID: 3324527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta receptor blockaders in heart therapy].
    Krosch H; Rikirsch P; Teichmann W
    Z Arztl Fortbild (Jena); 1970 Mar; 64(6):280-4. PubMed ID: 4397367
    [No Abstract]   [Full Text] [Related]  

  • 20. [Obstructive hypertrophic myocardiopathy].
    Camerini F; Fonda F; Greco M
    Minerva Pediatr; 1977 Mar; 29(7):427-30. PubMed ID: 17058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.